[Injectable contraceptive: nuclear effects after use].
Figueira
T D
TD
D000830:Animals, Laboratory; D001695:Biology; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D004194:Disease; D004467:Economics; D004703:Endocrine System; D004717:Endometrium; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D005835:Genitalia; D005836:Genitalia, Female; D006728:Hormones; D007267:Injections; D017258:Medroxyprogesterone Acetate; D010827:Physiology; D012102:Reproductive Control Agents; D012106:Research; D013672:Technology; D014566:Urogenital System; D014599:Uterus
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D006728:Hormones; D012102:Reproductive Control Agents; D017258:Medroxyprogesterone Acetate
Animals, Laboratory; Biology; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Diseases; Economic Factors; Endocrine System; Endometrial Effects; Endometrium; Evaluation; Family Planning; Genital Effects, Female; Genitalia; Genitalia, Female; Hormones; Injectables; Medroxyprogesterone Acetate; Physiology; Reproductive Control Agents; Research And Development; Research Methodology; Technology; Urogenital Effects; Urogenital System; Uterine Effects; Uterus